Contract award notice

Information

Published

Date of dispatch of this notice: 22/11/2021

External Reference: 2021-240665

TED Reference: 2021/S 230-604009

Contract award notice

Contract award notice

Results of the procurement procedure

Directive 2014/24/EU

Section I: Contracting authority

I.1)

Name and addresses

Health Service Executive (HSE)
N/A
Head Office
Naas
Millennium Park
IE
Contact person: Oonagh Walsh
Telephone: +353 567784539
NUTS code:  IE -  IRELAND
Internet address(es):
Main address: http://www.hse.ie

I.2)

Joint procurement

The contract is awarded by a central purchasing body
I.4)

Type of the contracting authority

Body governed by public law
I.5)

Main activity

Health

Section II: Object

II.1)

Scope of the procurement

II.1.1)

Title

Invitation to Tender for the Provision of Infliximab Pharmaceutical Product for Letterkenny University Hospital
Reference number:  HSE 14102
II.1.2)

Main CPV code

33600000  -  Pharmaceutical products
II.1.3)

Type of contract

Supplies
II.1.4)

Short description

Letterkenny University Hospital is a 360 bedded Hospital, providing a wide range of acute hospital services, on an in-patient, day-case and out-patient basis.
The recent annual usage of Infliximab 100mg vials is approximately 2,950 vials.It is intended to award the Contract to the Tenderer who, in the professional judgement of the Evaluation Group, submits the most economically advantageous tender having regard to the Award Criteria and Weightings outlined in the invitation to Tender.
II.1.6)

Information about lots

This contract is divided into lots: no
II.1.7)

Total value of the procurement

Value excluding VAT:  1.00  EUR
II.2)

Description

II.2.2)

Additional CPV code(s)

33600000  -  Pharmaceutical products
II.2.3)

Place of performance

NUTS code:  IE -  IRELAND
Main site or place of performance:  
Letterkenny
II.2.4)

Description of the procurement

Letterkenny University Hospital is a 360 bedded Hospital, providing a wide range of acute hospital services, on an in-patient, day-case and out-patient basis.
The recent annual usage of Infliximab 100mg vials is approximately 2,950 vials.It is intended to award the Contract to the Tenderer who, in the professional judgement of the Evaluation Group, submits the most economically advantageous tender having regard to the Award Criteria and Weightings outlined in the invitation to Tender.
II.2.5)

Award criteria

Criteria below
Quality criterion  -  Name:  Quality  /  Weighting:  54%
Quality criterion  -  Name:  Contract Mgt  /  Weighting:  6%
Cost criterion  -  Name:  Cost  /  Weighting:  40%
II.2.11)

Information about options

Options: no
II.2.13)

Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

Section IV: Procedure

IV.1)

Description

IV.1.1)

Type of procedure

Open procedure
IV.1.8)

Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement : yes
IV.2)

Administrative information

IV.2.1)

Previous publication concerning this procedure

Notice number in the OJ S: 2020/S 183-441487

Section V: Award of contract

Contract No: 1

Title: Invitation to Tender for the Provision of Infliximab Pharmaceutical Product for Letterkenny University Hospital

A contract/lot is awarded: yes
V.2)

Award of contract

V.2.1)

Date of conclusion of the contract

29/09/2021
V.2.2)

Information about tenders

Number of tenders received:  4
Number of tenders received by electronic means:  4
The contract has been awarded to a group of economic operators :  no
V.2.3)

Name and address of the contractor

BIOGEN IDEC (IRELAND) LTD
9576393Q
United Drug House Magna Business Park Magna Drive, Citywest Rd
Dublin
Dublin 24
IE
Telephone: +353 314637725
NUTS code:  IE -  IRELAND
Internet address: http://www.biogen.com

The contractor is an SME : no
V.2.4)

Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:  1.00  EUR
Total value of the contract/lot:  1.00  EUR

Section VI: Complementary information

VI.4)

Procedures for review

VI.4.1)

Review body

High Court
Four Courts
Dublin
1
IE

VI.4.3)

Review procedure

Precise information on deadline(s) for review procedures: 
As above